Pacb.com

ABSTRACT:- Nanomedicine is the process of diagnosing, treating, and preventing disease and traumatic injury, of relieving pain, and of preserving and improving human health, using molecular tools and molecular knowledge of the human body. In the relatively...

LSPPPO|HEALTHCARE NEWS|October 18, 2012 Healthcare News A Weekly Compilation of Clinical Laboratory and Related Information from The Division of Laboratory Science and Standards October 18, 2012 News Highlights President's Ethics Panel Urges New...

Competition is fierce among biotech companies vying to bring out radical new genome sequencing machines, and it's not at all clear who has the best approach. But a cutting-edge technique called single-molecule sequencing just got a boost from a team...

Cantor Fitzgerald analyst Bryan Brokmeier reiterated a Buy rating on Pacific Biosciences (NASDAQ: PACB) today and set a price target of $8. The company’s shares opened today at $4.84, close to its 52-week low of $3.76. According to TipRanks.com, Brokmeier...

This post was originally published on this site Sequel™ System Offers Significantly Higher Throughput, Reducing Project Costs and TimelinesMENLO PARK, Calif., Sept. 30, 2015 /satPRnews.com/ — Pacific Biosciences of California, Inc., (NASDAQ:PACB) a...